Brain Changes in Stimulant Dependent Subjects - 8
Public ClinicalTrials.gov record NCT00000343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Brain Changes in Stimulant Dependent Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to identify the neurophysiologic indicators of cocaine or methamphetamine use and withdrawal, to examine the relationship between subjects' reports of depression, craving, and stimulant use, and neurophysiologic measures, and to identify neurophysiologic measures which can be used to identify new treatments for stimulant dependence.
Study identification
- NCT ID
- NCT00000343
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 1996
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jan 11, 2017
Started 1996
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Friends Research Institute | Los Angeles | California | 90025 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Substance-Related Disorders trials
Other public records listing Substance-Related Disorders. Sorted by last update posted; newest first. Not a recommendation.
- NCT06548490: GLP-1R Agonist Treatment for Opioid Use Disorder Recruiting
- NCT07725289: Clinician Practice Companion to Address Youth Substance Use Not yet recruiting
- NCT06676059: SMART-r: Substance Monitoring and Active Relapse Tracking Repository Recruiting
- NCT05400252: Whole Health in VA Mental Health: Omnis Salutis Active, not recruiting
- NCT06236100: Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program Recruiting
- NCT05054738: CRP and S&A for Inpatient Veterans Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00000343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2017 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00000343 live on ClinicalTrials.gov.